BLVRA exerts its biological effects to induce malignant properties of hepatocellular carcinoma cells via Wnt/β-catenin pathway
- 13 January 2024
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 55 (2) , 159-167
Abstract
The function of Biliverdin Reductase A (BLVRA) in hepatocellular carcinoma (HCC) cells proliferation, invasion and migration remains unclear. Therefore, this research intends to explore the effect of BLVRA on HCC cells growth and metastasis. BLVRA expression was analyzed in public dataset and examined by using western blot. The malignant function of BLVRA in HCC cell lines and its effect on Wnt/β-catenin pathway were measured. Analysis from GEPIA website showed that BLVRA expression was significantly increased in HCC tissues, and high expression of BLVRA resulted in worse prognosis of HCC patients. Results from western blot showed that BLVRA expression was obviously increased in HCC cell lines. Moreover, HepG2 and Hep3B cells in si-BLVRA-1 or si-BLVRA-2 group displayed an obvious reduction in its proliferation, cell cycle, invasion and migration compared to those in the si-control group. Additionally, si-BLVRA-1 or si-BLVRA-2 transfection significantly reduced the protein levels of Vimentin, Snail1 and Snail2, as well as decreased Bcl-2 expression and increased Bax and cleaved-caspase 3 expression. Furthermore, si-BLVRA treatment inhibited the protein levels of c-MYC, β-catenin, and Cyclin D1. After IWP-4 (Wnt/β-catenin inhibitor) treatment, the proliferation ability of HCC cells was significantly reduced. BLVRA expression was significantly increased in HCC tissues and cell lines, and knocked down of BLVRA could suppress the proliferation, invasion and migration in HCC cell lines, as well as induce cell apoptosis. Moreover, si-BLVRA transfection blocked the activation of Wnt/β-catenin pathway.Keywords
Funding Information
- National Science and Technology Major Project of the Ministry of Science and Technology of China (2018ZX10303502)
- the Second Batch of Discipline Construction Project of Traditional Chinese Medicine (STG-ZYX01-202101)
- Special Project for the Scientific Research of Traditional Chinese Medicine in Henan Province (2022JDZX018)
This publication has 26 references indexed in Scilit:
- A site-selective, irreversible inhibitor of the DNA replication auxiliary factor proliferating cell nuclear antigen (PCNA)Bioorganic & Medicinal Chemistry, 2014
- Regulation of PCNA–protein interactions for genome stabilityNature Reviews Molecular Cell Biology, 2013
- N-Cadherin Expression Is Associated with Acquisition of EMT Phenotype and with Enhanced Invasion in Erlotinib-Resistant Lung Cancer Cell LinesPLOS ONE, 2013
- Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinomaTumor Biology, 2012
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAsNature Cell Biology, 2009
- High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutationsInternational Journal of Cancer, 2004
- Molecular pathogenesis of human hepatocellular carcinomaNature Genetics, 2002
- Tumor heterogeneity in small hepatocellular carcinoma: Analysis of tumor cell proliferation, expression and mutation of p53 AND ?-cateninInternational Journal of Cancer, 2001
- N-Cadherin Expression in Human Prostate Carcinoma Cell LinesThe American Journal of Pathology, 1999
- The cyclin D1 gene is a target of the β-catenin/LEF-1 pathwayProceedings of the National Academy of Sciences, 1999